SlideShare ist ein Scribd-Unternehmen logo
1 von 7
Downloaden Sie, um offline zu lesen
Acknowledgement
DRIVE project has received funding from the Innovative
Medicines Initiative 2 Joint Undertaking under grant
agreement No 777363, This Joint Undertaking receives
support from the European Union’s Horizon 2020
research and innovation programme and EFPIA.
Getting involved in
DRIVE
Acknowledgement
DRIVE project has received funding from the Innovative
Medicines Initiative 2 Joint Undertaking under grant
agreement No 777363, This Joint Undertaking receives
support from the European Union’s Horizon 2020
research and innovation programme and EFPIA.
Topi Turunen, MD
FISABIO-Public Health
Sites in 2018/19
PHIs & NICs
• Austria
• Finland
• Italy
• Romania
• Spain-Valencia
• Spain-La Rioja
• [An additional
NPHI]
Universities & networks
• Bambino Gesu
children’s hospital (IT)
• CIRI-IT (IT)
• Helsinki Uni. Central
Hospital (FI)
• Kapodistrian
University of Athens
(GR)
• Uni. Surrey (UK)
• Vall d’Hebron Uni.
Hospital (ES)
• [An European
network]
??
Test-negative
design studies
Cohort studies
Novel & innovative
studies
Public organizations with
established IVE studies
Other research
organizations
Associate
partners
Research
collaborators
Annual call for tenders
Review by DRIVE SC
IVE studies &
sharing data
DRIVE annual
meetings
Scientific
discussion,
publications
Development
of innovative
methodology
Associated Partners and Research Collaborators receive
a compensation for participation in DRIVE activities
They retain the full ownership of their data
• Ethics Committee reviews for each study are handled
locally
• Data collection should be compatible with one of the
DRIVE research protocols (with the exception of
innovative studies)
• DRIVE accepts both individual-level pseudonymised
data and aggregated/anonymised data
www.drive-eu.org
Acknowledgement
DRIVE project has received funding from the Innovative
Medicines Initiative 2 Joint Undertaking under grant
agreement No 777363, This Joint Undertaking receives
support from the European Union’s Horizon 2020
research and innovation programme and EFPIA.
info@drive-eu.org
@drive_eu

Weitere ähnliche Inhalte

Was ist angesagt?

Ten Years of Open Access in the European Commission (2006-2015)
Ten Years of Open Access in the European Commission (2006-2015)Ten Years of Open Access in the European Commission (2006-2015)
Ten Years of Open Access in the European Commission (2006-2015)Jean-François Dechamp
 
#Horizon2020 and #OpenAccess in 10 minutes!
#Horizon2020 and #OpenAccess in 10 minutes!#Horizon2020 and #OpenAccess in 10 minutes!
#Horizon2020 and #OpenAccess in 10 minutes!Jean-François Dechamp
 
Open Access Developments in Europe, Sept 2014
Open Access Developments in Europe, Sept 2014Open Access Developments in Europe, Sept 2014
Open Access Developments in Europe, Sept 2014SPARC Europe
 
A research-friendly copyright environment in the digital age: a European pers...
A research-friendly copyright environment in the digital age: a European pers...A research-friendly copyright environment in the digital age: a European pers...
A research-friendly copyright environment in the digital age: a European pers...Jean-François Dechamp
 
Cessda saw task4-6_haguefocusgrppresentation_0616
Cessda saw task4-6_haguefocusgrppresentation_0616Cessda saw task4-6_haguefocusgrppresentation_0616
Cessda saw task4-6_haguefocusgrppresentation_0616Neil Beagrie
 
Open Access Presentation Update June 2015
Open Access Presentation Update June 2015Open Access Presentation Update June 2015
Open Access Presentation Update June 2015Jean-François Dechamp
 
The "How" of Open Access: Implementing Open Access in Universities
The "How" of Open Access: Implementing Open Access in UniversitiesThe "How" of Open Access: Implementing Open Access in Universities
The "How" of Open Access: Implementing Open Access in UniversitiesJisc
 
Opening clinical trial data
Opening clinical trial dataOpening clinical trial data
Opening clinical trial dataEFSA EU
 
FWF Open Access Policy 2014
FWF Open Access Policy 2014FWF Open Access Policy 2014
FWF Open Access Policy 2014fjrrest
 
Updated presentation on OA in H2020 and ERA (JF Dechamp, UNESCO workshop, Ber...
Updated presentation on OA in H2020 and ERA (JF Dechamp, UNESCO workshop, Ber...Updated presentation on OA in H2020 and ERA (JF Dechamp, UNESCO workshop, Ber...
Updated presentation on OA in H2020 and ERA (JF Dechamp, UNESCO workshop, Ber...Jean-François Dechamp
 
NeuroRescescue EU Cluster of Excellence on Neuroscience
NeuroRescescue EU Cluster of Excellence on NeuroscienceNeuroRescescue EU Cluster of Excellence on Neuroscience
NeuroRescescue EU Cluster of Excellence on NeurosciencePARC DE SALUT
 
EPA H2020 SC5 Info Day: Horizon 2020 – Societal Challenge 5 Can we improve ...
 EPA H2020 SC5 Info Day: Horizon 2020 – Societal Challenge 5 Can we improve ... EPA H2020 SC5 Info Day: Horizon 2020 – Societal Challenge 5 Can we improve ...
EPA H2020 SC5 Info Day: Horizon 2020 – Societal Challenge 5 Can we improve ...Environmental Protection Agency, Ireland
 
NordForsk Open Access Reykjavik 14-15/8-2014: H2020
NordForsk Open Access Reykjavik 14-15/8-2014: H2020NordForsk Open Access Reykjavik 14-15/8-2014: H2020
NordForsk Open Access Reykjavik 14-15/8-2014: H2020NordForsk
 
2018 burgelman tsoukala athens may 31_final
2018 burgelman tsoukala athens may 31_final2018 burgelman tsoukala athens may 31_final
2018 burgelman tsoukala athens may 31_finalVictoria Tsoukala
 

Was ist angesagt? (20)

Ten Years of Open Access in the European Commission (2006-2015)
Ten Years of Open Access in the European Commission (2006-2015)Ten Years of Open Access in the European Commission (2006-2015)
Ten Years of Open Access in the European Commission (2006-2015)
 
#Horizon2020 and #OpenAccess in 10 minutes!
#Horizon2020 and #OpenAccess in 10 minutes!#Horizon2020 and #OpenAccess in 10 minutes!
#Horizon2020 and #OpenAccess in 10 minutes!
 
Open Access Developments in Europe, Sept 2014
Open Access Developments in Europe, Sept 2014Open Access Developments in Europe, Sept 2014
Open Access Developments in Europe, Sept 2014
 
A research-friendly copyright environment in the digital age: a European pers...
A research-friendly copyright environment in the digital age: a European pers...A research-friendly copyright environment in the digital age: a European pers...
A research-friendly copyright environment in the digital age: a European pers...
 
Cessda saw task4-6_haguefocusgrppresentation_0616
Cessda saw task4-6_haguefocusgrppresentation_0616Cessda saw task4-6_haguefocusgrppresentation_0616
Cessda saw task4-6_haguefocusgrppresentation_0616
 
Open Access Presentation Update June 2015
Open Access Presentation Update June 2015Open Access Presentation Update June 2015
Open Access Presentation Update June 2015
 
The "How" of Open Access: Implementing Open Access in Universities
The "How" of Open Access: Implementing Open Access in UniversitiesThe "How" of Open Access: Implementing Open Access in Universities
The "How" of Open Access: Implementing Open Access in Universities
 
Opening clinical trial data
Opening clinical trial dataOpening clinical trial data
Opening clinical trial data
 
FWF Open Access Policy 2014
FWF Open Access Policy 2014FWF Open Access Policy 2014
FWF Open Access Policy 2014
 
Updated presentation on OA in H2020 and ERA (JF Dechamp, UNESCO workshop, Ber...
Updated presentation on OA in H2020 and ERA (JF Dechamp, UNESCO workshop, Ber...Updated presentation on OA in H2020 and ERA (JF Dechamp, UNESCO workshop, Ber...
Updated presentation on OA in H2020 and ERA (JF Dechamp, UNESCO workshop, Ber...
 
EPA H2020 SC5 Info Day Book of Abstracts
 EPA H2020 SC5 Info Day Book of Abstracts EPA H2020 SC5 Info Day Book of Abstracts
EPA H2020 SC5 Info Day Book of Abstracts
 
HCF 2016: Bob Diderich
HCF 2016: Bob DiderichHCF 2016: Bob Diderich
HCF 2016: Bob Diderich
 
6 4 era-bled_knowledge_sharing_ff
6 4 era-bled_knowledge_sharing_ff6 4 era-bled_knowledge_sharing_ff
6 4 era-bled_knowledge_sharing_ff
 
Katarzyna Szkuta: "The European Open Science Cloud and the Open Science Policy"
Katarzyna Szkuta: "The European Open Science Cloud and the Open Science Policy"Katarzyna Szkuta: "The European Open Science Cloud and the Open Science Policy"
Katarzyna Szkuta: "The European Open Science Cloud and the Open Science Policy"
 
HCF 2016: Jake Sanderson
HCF 2016: Jake SandersonHCF 2016: Jake Sanderson
HCF 2016: Jake Sanderson
 
NeuroRescescue EU Cluster of Excellence on Neuroscience
NeuroRescescue EU Cluster of Excellence on NeuroscienceNeuroRescescue EU Cluster of Excellence on Neuroscience
NeuroRescescue EU Cluster of Excellence on Neuroscience
 
EPA H2020 SC5 Info Day: Horizon 2020 – Societal Challenge 5 Can we improve ...
 EPA H2020 SC5 Info Day: Horizon 2020 – Societal Challenge 5 Can we improve ... EPA H2020 SC5 Info Day: Horizon 2020 – Societal Challenge 5 Can we improve ...
EPA H2020 SC5 Info Day: Horizon 2020 – Societal Challenge 5 Can we improve ...
 
250314 final hulbaek
250314 final hulbaek250314 final hulbaek
250314 final hulbaek
 
NordForsk Open Access Reykjavik 14-15/8-2014: H2020
NordForsk Open Access Reykjavik 14-15/8-2014: H2020NordForsk Open Access Reykjavik 14-15/8-2014: H2020
NordForsk Open Access Reykjavik 14-15/8-2014: H2020
 
2018 burgelman tsoukala athens may 31_final
2018 burgelman tsoukala athens may 31_final2018 burgelman tsoukala athens may 31_final
2018 burgelman tsoukala athens may 31_final
 

Ähnlich wie Getting involved in DRIVE - Topi Turunen FISABIO

EUPATI – EU: An overview (Eibhlin Mulroe, EUPATI / IPPOSI)
EUPATI – EU: An overview (Eibhlin Mulroe, EUPATI / IPPOSI)EUPATI – EU: An overview (Eibhlin Mulroe, EUPATI / IPPOSI)
EUPATI – EU: An overview (Eibhlin Mulroe, EUPATI / IPPOSI)Nowgen
 
Attracting EC Funding - Diana Salmen
Attracting EC Funding - Diana SalmenAttracting EC Funding - Diana Salmen
Attracting EC Funding - Diana SalmenHuman Variome Project
 
NCPE Annual Training Day - March 10th 2016 - Derick Mitchell
NCPE Annual Training Day - March 10th 2016 - Derick MitchellNCPE Annual Training Day - March 10th 2016 - Derick Mitchell
NCPE Annual Training Day - March 10th 2016 - Derick Mitchellipposi
 
Alpha One Conference - IPPOSI
Alpha One Conference - IPPOSIAlpha One Conference - IPPOSI
Alpha One Conference - IPPOSIipposi
 
PPPI - the involvement of patients or people in the design and development o...
PPPI -  the involvement of patients or people in the design and development o...PPPI -  the involvement of patients or people in the design and development o...
PPPI - the involvement of patients or people in the design and development o...ipposi
 
University of Limerick - Person Centred Healthcare - Derick Mitchell
University of Limerick - Person Centred Healthcare - Derick MitchellUniversity of Limerick - Person Centred Healthcare - Derick Mitchell
University of Limerick - Person Centred Healthcare - Derick Mitchellipposi
 
Roundtable discussion: Relevance of the DRIVE study platform and sustainabili...
Roundtable discussion: Relevance of the DRIVE study platform and sustainabili...Roundtable discussion: Relevance of the DRIVE study platform and sustainabili...
Roundtable discussion: Relevance of the DRIVE study platform and sustainabili...DRIVE research
 
Research managers jan 14th, 2016 - ipposi presentation
Research managers   jan 14th, 2016 - ipposi presentationResearch managers   jan 14th, 2016 - ipposi presentation
Research managers jan 14th, 2016 - ipposi presentationipposi
 
Colloque IMT - 15/10/2019 - Healthcare 4.0 – « EIT Health : un tremplin europ...
Colloque IMT - 15/10/2019 - Healthcare 4.0 – « EIT Health : un tremplin europ...Colloque IMT - 15/10/2019 - Healthcare 4.0 – « EIT Health : un tremplin europ...
Colloque IMT - 15/10/2019 - Healthcare 4.0 – « EIT Health : un tremplin europ...I MT
 
Patient-Centered Digital Health
Patient-Centered Digital HealthPatient-Centered Digital Health
Patient-Centered Digital Healthipposi
 
Introduction to the workshop and EUPATI update
Introduction to the workshop and EUPATI updateIntroduction to the workshop and EUPATI update
Introduction to the workshop and EUPATI updateEUPATI
 
Prostate cancer nov 11, 2015
Prostate cancer   nov 11, 2015Prostate cancer   nov 11, 2015
Prostate cancer nov 11, 2015ipposi
 
EUPATI 2013 Conference: Patient involvement in medicines R&D: Bringing to li...
EUPATI 2013 Conference: Patient involvement in medicines R&D: Bringing to li...EUPATI 2013 Conference: Patient involvement in medicines R&D: Bringing to li...
EUPATI 2013 Conference: Patient involvement in medicines R&D: Bringing to li...EUPATI
 
Croi Galway - Derick Mitchell - July 2016
Croi Galway - Derick Mitchell - July 2016Croi Galway - Derick Mitchell - July 2016
Croi Galway - Derick Mitchell - July 2016ipposi
 
IPPOSI Patient Education Programme - 2017/2018 pilot
IPPOSI Patient Education Programme - 2017/2018 pilotIPPOSI Patient Education Programme - 2017/2018 pilot
IPPOSI Patient Education Programme - 2017/2018 pilotipposi
 
Peter van der hijden at unica, brussels, 8 may 2013
Peter van der hijden at unica, brussels, 8 may 2013Peter van der hijden at unica, brussels, 8 may 2013
Peter van der hijden at unica, brussels, 8 may 2013Anneliesvub
 
CIRM 2014 eng
CIRM 2014 engCIRM 2014 eng
CIRM 2014 engLorenz
 
PPI Conference Galway - Dr Derick Mitchell - April 27th 2016
PPI Conference Galway - Dr Derick Mitchell - April 27th 2016PPI Conference Galway - Dr Derick Mitchell - April 27th 2016
PPI Conference Galway - Dr Derick Mitchell - April 27th 2016ipposi
 
EUPATI 2013 Conference: Vision on Patient involvement in medicines R&D: Here...
EUPATI 2013 Conference: Vision on Patient involvement in medicines R&D: Here...EUPATI 2013 Conference: Vision on Patient involvement in medicines R&D: Here...
EUPATI 2013 Conference: Vision on Patient involvement in medicines R&D: Here...EUPATI
 

Ähnlich wie Getting involved in DRIVE - Topi Turunen FISABIO (20)

EUPATI – EU: An overview (Eibhlin Mulroe, EUPATI / IPPOSI)
EUPATI – EU: An overview (Eibhlin Mulroe, EUPATI / IPPOSI)EUPATI – EU: An overview (Eibhlin Mulroe, EUPATI / IPPOSI)
EUPATI – EU: An overview (Eibhlin Mulroe, EUPATI / IPPOSI)
 
Attracting EC Funding - Diana Salmen
Attracting EC Funding - Diana SalmenAttracting EC Funding - Diana Salmen
Attracting EC Funding - Diana Salmen
 
NCPE Annual Training Day - March 10th 2016 - Derick Mitchell
NCPE Annual Training Day - March 10th 2016 - Derick MitchellNCPE Annual Training Day - March 10th 2016 - Derick Mitchell
NCPE Annual Training Day - March 10th 2016 - Derick Mitchell
 
Alpha One Conference - IPPOSI
Alpha One Conference - IPPOSIAlpha One Conference - IPPOSI
Alpha One Conference - IPPOSI
 
PPPI - the involvement of patients or people in the design and development o...
PPPI -  the involvement of patients or people in the design and development o...PPPI -  the involvement of patients or people in the design and development o...
PPPI - the involvement of patients or people in the design and development o...
 
University of Limerick - Person Centred Healthcare - Derick Mitchell
University of Limerick - Person Centred Healthcare - Derick MitchellUniversity of Limerick - Person Centred Healthcare - Derick Mitchell
University of Limerick - Person Centred Healthcare - Derick Mitchell
 
Roundtable discussion: Relevance of the DRIVE study platform and sustainabili...
Roundtable discussion: Relevance of the DRIVE study platform and sustainabili...Roundtable discussion: Relevance of the DRIVE study platform and sustainabili...
Roundtable discussion: Relevance of the DRIVE study platform and sustainabili...
 
Research managers jan 14th, 2016 - ipposi presentation
Research managers   jan 14th, 2016 - ipposi presentationResearch managers   jan 14th, 2016 - ipposi presentation
Research managers jan 14th, 2016 - ipposi presentation
 
Colloque IMT - 15/10/2019 - Healthcare 4.0 – « EIT Health : un tremplin europ...
Colloque IMT - 15/10/2019 - Healthcare 4.0 – « EIT Health : un tremplin europ...Colloque IMT - 15/10/2019 - Healthcare 4.0 – « EIT Health : un tremplin europ...
Colloque IMT - 15/10/2019 - Healthcare 4.0 – « EIT Health : un tremplin europ...
 
Patient-Centered Digital Health
Patient-Centered Digital HealthPatient-Centered Digital Health
Patient-Centered Digital Health
 
Introduction to the workshop and EUPATI update
Introduction to the workshop and EUPATI updateIntroduction to the workshop and EUPATI update
Introduction to the workshop and EUPATI update
 
Prostate cancer nov 11, 2015
Prostate cancer   nov 11, 2015Prostate cancer   nov 11, 2015
Prostate cancer nov 11, 2015
 
EUPATI 2013 Conference: Patient involvement in medicines R&D: Bringing to li...
EUPATI 2013 Conference: Patient involvement in medicines R&D: Bringing to li...EUPATI 2013 Conference: Patient involvement in medicines R&D: Bringing to li...
EUPATI 2013 Conference: Patient involvement in medicines R&D: Bringing to li...
 
Croi Galway - Derick Mitchell - July 2016
Croi Galway - Derick Mitchell - July 2016Croi Galway - Derick Mitchell - July 2016
Croi Galway - Derick Mitchell - July 2016
 
IPPOSI Patient Education Programme - 2017/2018 pilot
IPPOSI Patient Education Programme - 2017/2018 pilotIPPOSI Patient Education Programme - 2017/2018 pilot
IPPOSI Patient Education Programme - 2017/2018 pilot
 
Peter van der hijden at unica, brussels, 8 may 2013
Peter van der hijden at unica, brussels, 8 may 2013Peter van der hijden at unica, brussels, 8 may 2013
Peter van der hijden at unica, brussels, 8 may 2013
 
Pichler get real at ht ai- introduction
Pichler get real at  ht ai- introductionPichler get real at  ht ai- introduction
Pichler get real at ht ai- introduction
 
CIRM 2014 eng
CIRM 2014 engCIRM 2014 eng
CIRM 2014 eng
 
PPI Conference Galway - Dr Derick Mitchell - April 27th 2016
PPI Conference Galway - Dr Derick Mitchell - April 27th 2016PPI Conference Galway - Dr Derick Mitchell - April 27th 2016
PPI Conference Galway - Dr Derick Mitchell - April 27th 2016
 
EUPATI 2013 Conference: Vision on Patient involvement in medicines R&D: Here...
EUPATI 2013 Conference: Vision on Patient involvement in medicines R&D: Here...EUPATI 2013 Conference: Vision on Patient involvement in medicines R&D: Here...
EUPATI 2013 Conference: Vision on Patient involvement in medicines R&D: Here...
 

Mehr von DRIVE research

Dissemination of Pilot Year Outcomes - Communications Workshop, Work Package 5
Dissemination of Pilot Year Outcomes - Communications Workshop, Work Package 5Dissemination of Pilot Year Outcomes - Communications Workshop, Work Package 5
Dissemination of Pilot Year Outcomes - Communications Workshop, Work Package 5DRIVE research
 
DRIVE CENTRAL STUDY PLATFORM: Data flow, data quality and statistical analysi...
DRIVE CENTRAL STUDY PLATFORM: Data flow, data quality and statistical analysi...DRIVE CENTRAL STUDY PLATFORM: Data flow, data quality and statistical analysi...
DRIVE CENTRAL STUDY PLATFORM: Data flow, data quality and statistical analysi...DRIVE research
 
A study platform to generate brand specific influenza vaccine effectiveness: ...
A study platform to generate brand specific influenza vaccine effectiveness: ...A study platform to generate brand specific influenza vaccine effectiveness: ...
A study platform to generate brand specific influenza vaccine effectiveness: ...DRIVE research
 
DRIVE season 2018/2019
DRIVE season 2018/2019 DRIVE season 2018/2019
DRIVE season 2018/2019 DRIVE research
 
The Challenges of Pooling IVE estimates - Jos Nauta, Abbott
The Challenges of Pooling IVE estimates - Jos Nauta, AbbottThe Challenges of Pooling IVE estimates - Jos Nauta, Abbott
The Challenges of Pooling IVE estimates - Jos Nauta, AbbottDRIVE research
 
Previous exposure to natural infection matters, Ulrike Baum - ESCAIDE 2018
Previous exposure to natural infection matters, Ulrike Baum - ESCAIDE 2018Previous exposure to natural infection matters, Ulrike Baum - ESCAIDE 2018
Previous exposure to natural infection matters, Ulrike Baum - ESCAIDE 2018DRIVE research
 
Drive communication plan and debate - Sharon McHale & Riia Järvenpää
Drive communication plan and debate - Sharon McHale & Riia JärvenpääDrive communication plan and debate - Sharon McHale & Riia Järvenpää
Drive communication plan and debate - Sharon McHale & Riia JärvenpääDRIVE research
 
Novel and innovative approaches for measuring influenza VE - Anke Stuurman P95
Novel and innovative approaches for measuring influenza VE - Anke Stuurman P95Novel and innovative approaches for measuring influenza VE - Anke Stuurman P95
Novel and innovative approaches for measuring influenza VE - Anke Stuurman P95DRIVE research
 
Brand specificities and study tools developed by DRIVE
Brand specificities and study tools developed by DRIVE Brand specificities and study tools developed by DRIVE
Brand specificities and study tools developed by DRIVE DRIVE research
 
Governance in DRIVE - Laurence Torcel-Paignon Sanofi Pasteur
Governance in DRIVE - Laurence Torcel-Paignon Sanofi PasteurGovernance in DRIVE - Laurence Torcel-Paignon Sanofi Pasteur
Governance in DRIVE - Laurence Torcel-Paignon Sanofi PasteurDRIVE research
 
Influenza vaccine effectiveness studies in Europe - Pasi Penttinen ECDC
Influenza vaccine effectiveness studies in Europe - Pasi Penttinen ECDCInfluenza vaccine effectiveness studies in Europe - Pasi Penttinen ECDC
Influenza vaccine effectiveness studies in Europe - Pasi Penttinen ECDCDRIVE research
 
Regulatory requirements for influenza vaccines - Marco Cavaleri EMA
Regulatory requirements for influenza vaccines - Marco Cavaleri EMARegulatory requirements for influenza vaccines - Marco Cavaleri EMA
Regulatory requirements for influenza vaccines - Marco Cavaleri EMADRIVE research
 
Introduction to DRIVE - Cedric Mahe
Introduction to DRIVE - Cedric MaheIntroduction to DRIVE - Cedric Mahe
Introduction to DRIVE - Cedric MaheDRIVE research
 

Mehr von DRIVE research (13)

Dissemination of Pilot Year Outcomes - Communications Workshop, Work Package 5
Dissemination of Pilot Year Outcomes - Communications Workshop, Work Package 5Dissemination of Pilot Year Outcomes - Communications Workshop, Work Package 5
Dissemination of Pilot Year Outcomes - Communications Workshop, Work Package 5
 
DRIVE CENTRAL STUDY PLATFORM: Data flow, data quality and statistical analysi...
DRIVE CENTRAL STUDY PLATFORM: Data flow, data quality and statistical analysi...DRIVE CENTRAL STUDY PLATFORM: Data flow, data quality and statistical analysi...
DRIVE CENTRAL STUDY PLATFORM: Data flow, data quality and statistical analysi...
 
A study platform to generate brand specific influenza vaccine effectiveness: ...
A study platform to generate brand specific influenza vaccine effectiveness: ...A study platform to generate brand specific influenza vaccine effectiveness: ...
A study platform to generate brand specific influenza vaccine effectiveness: ...
 
DRIVE season 2018/2019
DRIVE season 2018/2019 DRIVE season 2018/2019
DRIVE season 2018/2019
 
The Challenges of Pooling IVE estimates - Jos Nauta, Abbott
The Challenges of Pooling IVE estimates - Jos Nauta, AbbottThe Challenges of Pooling IVE estimates - Jos Nauta, Abbott
The Challenges of Pooling IVE estimates - Jos Nauta, Abbott
 
Previous exposure to natural infection matters, Ulrike Baum - ESCAIDE 2018
Previous exposure to natural infection matters, Ulrike Baum - ESCAIDE 2018Previous exposure to natural infection matters, Ulrike Baum - ESCAIDE 2018
Previous exposure to natural infection matters, Ulrike Baum - ESCAIDE 2018
 
Drive communication plan and debate - Sharon McHale & Riia Järvenpää
Drive communication plan and debate - Sharon McHale & Riia JärvenpääDrive communication plan and debate - Sharon McHale & Riia Järvenpää
Drive communication plan and debate - Sharon McHale & Riia Järvenpää
 
Novel and innovative approaches for measuring influenza VE - Anke Stuurman P95
Novel and innovative approaches for measuring influenza VE - Anke Stuurman P95Novel and innovative approaches for measuring influenza VE - Anke Stuurman P95
Novel and innovative approaches for measuring influenza VE - Anke Stuurman P95
 
Brand specificities and study tools developed by DRIVE
Brand specificities and study tools developed by DRIVE Brand specificities and study tools developed by DRIVE
Brand specificities and study tools developed by DRIVE
 
Governance in DRIVE - Laurence Torcel-Paignon Sanofi Pasteur
Governance in DRIVE - Laurence Torcel-Paignon Sanofi PasteurGovernance in DRIVE - Laurence Torcel-Paignon Sanofi Pasteur
Governance in DRIVE - Laurence Torcel-Paignon Sanofi Pasteur
 
Influenza vaccine effectiveness studies in Europe - Pasi Penttinen ECDC
Influenza vaccine effectiveness studies in Europe - Pasi Penttinen ECDCInfluenza vaccine effectiveness studies in Europe - Pasi Penttinen ECDC
Influenza vaccine effectiveness studies in Europe - Pasi Penttinen ECDC
 
Regulatory requirements for influenza vaccines - Marco Cavaleri EMA
Regulatory requirements for influenza vaccines - Marco Cavaleri EMARegulatory requirements for influenza vaccines - Marco Cavaleri EMA
Regulatory requirements for influenza vaccines - Marco Cavaleri EMA
 
Introduction to DRIVE - Cedric Mahe
Introduction to DRIVE - Cedric MaheIntroduction to DRIVE - Cedric Mahe
Introduction to DRIVE - Cedric Mahe
 

Kürzlich hochgeladen

Tans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxTans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxKezaiah S
 
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranTara Rajendran
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisGolden Helix
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdfDolisha Warbi
 
Nutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience ClassNutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience Classmanuelazg2001
 
PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..AneriPatwari
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptxMohamed Rizk Khodair
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiGoogle
 
Plant Fibres used as Surgical Dressings PDF.pdf
Plant Fibres used as Surgical Dressings PDF.pdfPlant Fibres used as Surgical Dressings PDF.pdf
Plant Fibres used as Surgical Dressings PDF.pdfDivya Kanojiya
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptxTina Purnat
 
medico legal aspects of wound - forensic medicine
medico legal aspects of wound - forensic medicinemedico legal aspects of wound - forensic medicine
medico legal aspects of wound - forensic medicinethanaram patel
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfSasikiranMarri
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.ANJALI
 
World-Health-Day-2024-My-Health-My-Right.pptx
World-Health-Day-2024-My-Health-My-Right.pptxWorld-Health-Day-2024-My-Health-My-Right.pptx
World-Health-Day-2024-My-Health-My-Right.pptxEx WHO/USAID
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxDr. Dheeraj Kumar
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Badalona Serveis Assistencials
 
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)MohamadAlhes
 
L1.INTRODUCTION to ENDOCRINOLOGY MEDICINE.pptx
L1.INTRODUCTION to ENDOCRINOLOGY MEDICINE.pptxL1.INTRODUCTION to ENDOCRINOLOGY MEDICINE.pptx
L1.INTRODUCTION to ENDOCRINOLOGY MEDICINE.pptxDr Bilal Natiq
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...sdateam0
 

Kürzlich hochgeladen (20)

Tans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxTans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptx
 
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
 
Nutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience ClassNutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience Class
 
PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptx
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali Rai
 
Plant Fibres used as Surgical Dressings PDF.pdf
Plant Fibres used as Surgical Dressings PDF.pdfPlant Fibres used as Surgical Dressings PDF.pdf
Plant Fibres used as Surgical Dressings PDF.pdf
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptx
 
medico legal aspects of wound - forensic medicine
medico legal aspects of wound - forensic medicinemedico legal aspects of wound - forensic medicine
medico legal aspects of wound - forensic medicine
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdf
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.
 
World-Health-Day-2024-My-Health-My-Right.pptx
World-Health-Day-2024-My-Health-My-Right.pptxWorld-Health-Day-2024-My-Health-My-Right.pptx
World-Health-Day-2024-My-Health-My-Right.pptx
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptx
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
 
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)
 
L1.INTRODUCTION to ENDOCRINOLOGY MEDICINE.pptx
L1.INTRODUCTION to ENDOCRINOLOGY MEDICINE.pptxL1.INTRODUCTION to ENDOCRINOLOGY MEDICINE.pptx
L1.INTRODUCTION to ENDOCRINOLOGY MEDICINE.pptx
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
 

Getting involved in DRIVE - Topi Turunen FISABIO

  • 1. Acknowledgement DRIVE project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 777363, This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA. Getting involved in DRIVE Acknowledgement DRIVE project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 777363, This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA. Topi Turunen, MD FISABIO-Public Health
  • 2. Sites in 2018/19 PHIs & NICs • Austria • Finland • Italy • Romania • Spain-Valencia • Spain-La Rioja • [An additional NPHI] Universities & networks • Bambino Gesu children’s hospital (IT) • CIRI-IT (IT) • Helsinki Uni. Central Hospital (FI) • Kapodistrian University of Athens (GR) • Uni. Surrey (UK) • Vall d’Hebron Uni. Hospital (ES) • [An European network] ??
  • 4. Public organizations with established IVE studies Other research organizations Associate partners Research collaborators Annual call for tenders Review by DRIVE SC
  • 5. IVE studies & sharing data DRIVE annual meetings Scientific discussion, publications Development of innovative methodology Associated Partners and Research Collaborators receive a compensation for participation in DRIVE activities They retain the full ownership of their data
  • 6. • Ethics Committee reviews for each study are handled locally • Data collection should be compatible with one of the DRIVE research protocols (with the exception of innovative studies) • DRIVE accepts both individual-level pseudonymised data and aggregated/anonymised data
  • 7. www.drive-eu.org Acknowledgement DRIVE project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 777363, This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA. info@drive-eu.org @drive_eu